Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., May 16, 2023 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO),…
SOUTH SAN FRANCISCO, Calif., May 16, 2023 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO),…
Full Year 2022 total revenues with double-digit growth of 12% at €47.5 million, in line…
Vancouver, British Columbia–(Newsfile Corp. – May 16, 2023) – Marble Financial Inc. (CSE: MRBL) (OTC…
DENVER, CO, May 17, 2023 – (ACN Newswire) – Neeyamo, a market leader in global…
LOS ANGELES, CA, May 17, 2023 – (ACN Newswire) – The Tera 75 is AZIO’s…
3M and Svante will partner to develop Direct Air Capture (DAC) products for the carbon…
PARIS, FRANCE, May 17, 2023 – (ACN Newswire) – AI Biotech Owkin, a leading provider…
KIEL, GERMANY, May 17, 2023 – (ACN Newswire) – tiakis Biotech AG (tiakis), in collaboration…
SANTA MONICA, Calif.,–(BUSINESS WIRE)–Autonomy™, the nation’s largest electric vehicle subscription company, announced that auto finance…
Veryfi Lens fuels global loyalty campaigns with instant purchase validation and cross-basket insights SAN MATEO,…
LAS VEGAS–(BUSINESS WIRE)–Epicor, a global leader of industry-specific enterprise software to promote business growth, will…
Infant Bacterial Therapeutics AB (publ), Reg. No. 556873-8586, with its registered office in Stockholm, gives notice…
Infant Bacterial Therapeutics AB (publ), Reg. No. 556873-8586, with its registered office in Stockholm, gives notice…
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
Company on track to complete planned interim analyses from two ongoing Phase 2 studies of…
Company on track to complete planned interim analyses from two ongoing Phase 2 studies of…
Michelle Robertson to remain with Company until August 16, 2023 Erick Lucera Editas Medicine today…
Michelle Robertson to remain with Company until August 16, 2023 Erick Lucera Editas Medicine today…
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…